Pamela Carroll, Ph.D. is the president at Silicon Therapeutics and brings extensive experience leading oncology drug discovery and business development.
Dr. Carroll joined Silicon Therapeutics in August 2020 as chief business officer. Prior to joining Silicon Therapeutics, Dr. Carroll served as senior vice president of immuno-oncology at Genocea Biosciences where she spearheaded the company development of vaccines and cell therapies. Before Genocea, Dr. Carroll held the position of vice president at Janssen Oncology-Johnson and Johnson Innovation leading strategic partnerships, new company investments and academic collaborations. She successfully led drug discovery at other organizations including vice president of Roche Oncology Discovery, head of research at the Belfer Institute for Applied Cancer Sciences at Dana Farber Cancer Center and Harvard Medical School. Earlier in her career, Dr. Carroll served as director of cancer pathways at Merck Research Laboratories, and senior investigator in applied genomics at Bristol Myers Squibb. Dr. Carroll earned a bachelor of science degree in biology from Saint Michael’s College in Colchester, Vt., a doctor of philosophy in cell biology from Stony Brook University and completed a postdoctoral fellowship at Stanford University in Stanford, Calif.